Harnessing Your Abilities to Convert RFPs into Awarded Clinical Trials
Use the psychology and management you have to turn your proposal strategies into a learnable, competitive advantage
WHAT WE DO
Technical capability alone does not win business
The Clinical Trial Education Institute LLC (CTEl) is a specialized education and advisory firm helping clinical research professionals and teams compete more effectively for clinical development opportunities by improving their understanding of the operational psychology, team collaboration, interpersonal skills, and time management. Blending these more effectively means competing more effectively.
We see a gap in the way that professionals and teams are trained for the proposals and bid defenses. CTEI bridges that gap by offering an expanded understanding of the proposal and bid defense spectrum through coaching, training, and rigor. We coach on the strategy behind your strategy - making you the most knowledgeable and effective team member you can be at the time you need it.
HOW WE DO IT
Our Bid Defense Crash Courses
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
30-minute to 2-hour, online, self-paced course offerings that better prepare team members for the 1st, 2nd, or biggest bid defense meeting of their careers, from clinical research associates to executives.
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
A practical, team-based program that strengthens opportunity qualification, competitive positioning, win-theme development, proposal planning, and sponsor-centered storytelling.
Our Bid Defense Readiness Lab
Our Proposal Strategy Bootcamp
Our Bid Defense Readiness Lab
An immersive preparation experience that helps teams sharpen executive presence, align cross-functional messaging, anticipate sponsor questions, and perform with confidence under pressure.
WHO WE ARE
Your CTEI Team
Christopher Morley, MPH
Christopher Morley, MPH
Over the past 2+ decades the CTEI team has become one of the CRO industry’s most relied-upon therapeutic subject matter experts for clinical services RFPs and bid defense strategy. They have led or contributed to more than 2,000 RFPs, reviewed over 1,000 clinical protocols, and served as the lead clinical strategist in more than 350 bid d
Over the past 2+ decades the CTEI team has become one of the CRO industry’s most relied-upon therapeutic subject matter experts for clinical services RFPs and bid defense strategy. They have led or contributed to more than 2,000 RFPs, reviewed over 1,000 clinical protocols, and served as the lead clinical strategist in more than 350 bid defense meetings—directly influencing revenue growth and award outcomes for employers in excess of $800M of revenue. Their specialization in early-late phase, study design, feasibility optimization, competitive landscape analysis, and patient recruitment strategy has equipped both CROs and biotech sponsors with high-impact guidance that strengthens proposals, elevates client confidence, and improves win probability. Through CTEI the team now delivers this same level of precision, insight, and strategic clarity to clients navigating today’s complex global clinical trial environment.
Christopher Morley, MPH
Christopher Morley, MPH
Christopher Morley, MPH
As a proud US military veteran and clinical research professional, Christopher brings 25 years of industry experience across both clinical development strategy and operations. For well over a decade he has managed and led bidding and operational teams across the spectrum of the RFP process. Spanning operational roles from Clinical Researc
As a proud US military veteran and clinical research professional, Christopher brings 25 years of industry experience across both clinical development strategy and operations. For well over a decade he has managed and led bidding and operational teams across the spectrum of the RFP process. Spanning operational roles from Clinical Research Associate up to Portfolio Director across biotech and pharmaceutical programs in multiple therapeutic areas and treatment modalities, he has seen the nuances of how delivery teams find success through strong planning, risk mitigation, and team coordination at all levels. Christopher holds a MPH from Emory University and a BS from Georgia State University. Prior to his work in clinical research, Christopher proudly served in the United States Marine Corps.
Nathan Currier, PhD
Christopher Morley, MPH
Nathan Currier, PhD
Nathan brings more than 28 years of cross-sector experience spanning pre-clinical research, clinical development, biotechnology, NGOs, and academic oncology. He has spent the last decade leading therapeutic strategy for RFPs, proposals, client-presentations, and bid defenses across 2 different CROs. With a PhD in cellular and molecular bi
Nathan brings more than 28 years of cross-sector experience spanning pre-clinical research, clinical development, biotechnology, NGOs, and academic oncology. He has spent the last decade leading therapeutic strategy for RFPs, proposals, client-presentations, and bid defenses across 2 different CROs. With a PhD in cellular and molecular biology from McGill University, his academic work centered on NK-cell-mediated amelioration of erythroleukemia (Di Guglielmo Syndrome). Across his career, he has contributed to fundamental oncology research, pediatric neuroblastoma studies involving radioligand modalities, and executive-level clinical strategy roles guiding global development programs. His expertise bridges scientific rigor, operational execution, and strategic leadership across the full continuum of oncology research.